Rallybio Corporation
RLYBBiotechnology
$15.41−3.63%As of Oct 29vs prior close
- Market cap
- $83M
- P/E (TTM)
- 3.3×
- From 52W high
- −10.51%
- EPS (LTM)
- $4.61
- Revenue (LTM)
- $434K
- Net margin
- 6177.42%
- Dividend yield
- 0.00%
Nomior Score
61
Steady ProfileSpeculativeTop 25% of the scored universe
Growth42
Quality52
Value—
Momentum97
Resilience44
Growth
+34.91%revenue a year over 1 fiscal year
YE24 $636KLTM $434K
Connections
Revenue to profitQ1 YE26
The operating loss was 4119% of revenue, narrower by 442 pts on a year.
Who owns it
1fund, 1 tracked portfolio